OrthoPediatrics Corp.
General ticker "KIDS" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $508.2M (TTM average)
OrthoPediatrics Corp. does not follow the US Stock Market performance with the rate: -11.7%.
Estimated limits based on current volatility of 2.0%: low 17.78$, high 18.50$
Factors to consider:
- Total employees count: 562 (+127.5%) as of 2024
- US accounted for 78.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Pandemic risks, Economic downturns and volatility, Access to capital, Reimbursement risks, Market volatility
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.04$, 29.05$]
- 2025-12-31 to 2026-12-31 estimated range: [11.26$, 27.00$]
Financial Metrics affecting the KIDS estimates:
- Negative: with PPE of -22.7 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.16 <= 0.33
- Positive: Shareholder equity ratio, % of 74.93 > 63.39
- Positive: Interest expense per share per price, % of 0.50 <= 0.79
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: -4.48 < Investing cash flow per share per price, % of -2.51
- Positive: Inventory ratio change, % of -5.21 <= -0.75
Short-term KIDS quotes
Long-term KIDS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $122.29MM | $148.73MM | $204.73MM |
| Operating Expenses | $147.69MM | $175.48MM | $239.74MM |
| Operating Income | $-25.40MM | $-26.75MM | $-35.01MM |
| Non-Operating Income | $21.71MM | $5.44MM | $-6.92MM |
| Interest Expense | $2.42MM | $0.20MM | $2.62MM |
| R&D Expense | $8.45MM | $10.89MM | $11.03MM |
| Income(Loss) | $-3.69MM | $-21.31MM | $-41.93MM |
| Taxes | $-4.95MM | $-0.34MM | $-4.11MM |
| Profit(Loss)* | $1.26MM | $-20.97MM | $-37.82MM |
| Stockholders Equity | $378.65MM | $377.02MM | $354.57MM |
| Inventory | $78.19MM | $105.85MM | $117.00MM |
| Assets | $427.73MM | $438.75MM | $473.21MM |
| Operating Cash Flow | $-21.77MM | $-27.05MM | $-27.05MM |
| Capital expenditure | $10.03MM | $18.98MM | $14.26MM |
| Investing Cash Flow | $-113.37MM | $41.68MM | $-13.16MM |
| Financing Cash Flow | $135.97MM | $7.30MM | $53.13MM |
| Earnings Per Share** | $0.06 | $-0.92 | $-1.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.